In what appears to be a significant step forward in the battle against child mortality in Nigeria, the Sarmaan Project, an initiative centered around strategic drug administration for infants, has made headlines for successfully treating over 36,000 children during its pilot phase in Ikono Local Government Area (LGA) of Akwa Ibom State. This milestone not only marks a major victory in public health interventions but also opens a promising chapter in child survival efforts across Nigeria.
At the heart of the project is the administration of azithromycin, a widely used antibiotic known for treating various bacterial infections. The Sarmaan Project, driven by the international non-governmental organization Sightsavers, aims to explore the life-saving potential of the drug when administered to children aged between 1 to 11 months.
During a close-out event held in Uyo, the capital of Akwa Ibom State, Dr. Teyil Wamiyel-Mshella, the Project Coordinator, provided insights into the initiative’s purpose, reach, and future potential. According to her, the focus of the pilot was not only on administering the drug but also on closely monitoring its safety and tracking any emergence of antimicrobial resistance — two critical factors in the fight against pediatric infections.
Azithromycin as a Child Survival Strategy
“Azithromycin is a proven antibiotic with wide applications, particularly in treating respiratory and other bacterial infections that disproportionately affect children,” Wamiyel-Mshella noted. “We wanted to scientifically validate its role in reducing mortality in children under five, especially those between 1 to 11 months.”
The implementation strategy revolved around mass drug administration (MDA), a technique endorsed by global health bodies like the World Health Organization (WHO), especially in low-resource settings. Through MDA, all eligible children in the targeted age group were given a dose of azithromycin every six months over a two-year period, from 2022 to 2024.
This project, according to Wamiyel-Mshella, was not an isolated effort. It involved continuous engagement with caregivers, extensive data collection, and rigorous safety monitoring to ensure the efficacy and safety of the antibiotic across a diverse group of infants. One of the key deliverables was to observe any resistance patterns that might develop, thereby informing future antibiotic stewardship strategies in Nigeria and beyond.
Caregiver Engagement and Community Involvement
One of the most commendable aspects of the Sarmaan Project was its emphasis on community participation. From the outset, the project was designed to be inclusive, involving not just healthcare professionals but also caregivers and community leaders. This approach created a strong sense of ownership and awareness, which proved critical for the program’s success.
Caregivers, who play a pivotal role in the health and wellbeing of children, were trained and educated on the importance and benefits of azithromycin in preventing early childhood deaths. This grassroots-level engagement was instrumental in ensuring that the drugs were not only administered but also accepted and trusted by the community.
Wamiyel-Mshella highlighted how this inclusive model turned out to be a game-changer: “The level of support we received from caregivers and local leaders in Ikono was overwhelming. Their willingness to collaborate and their understanding of the project’s significance gave us the platform we needed to succeed.”
Government Endorsement and Policy Integration
The state government of Akwa Ibom was also an integral part of the pilot program’s success. At the closing ceremony, the state’s Commissioner for Health, Dr. Ekem John — represented by Dr. Etop Antia, Director of Public Health — expressed gratitude to all stakeholders and acknowledged the initiative’s impact in complementing ongoing child survival interventions.
Dr. Antia explained that the Sarmaan Project aligns perfectly with the state’s broader public health strategy, particularly through its integration with routine immunization programs. The synergy between immunization efforts and azithromycin administration created a comprehensive child health platform that offered preventive and curative interventions in one package.
“The Sarmaan Project offers an additional layer of protection for our children. By pairing this drug administration with our regular immunization schedules, we’re tackling childhood diseases from multiple angles,” Dr. Antia remarked.
He also emphasized the need for continuity and expansion, stating that the evidence from Ikono LGA could pave the way for a state-wide or even nationwide rollout. This, he added, would require sustained funding, stakeholder collaboration, and government buy-in at all levels.
The Role of National and International Partnerships
A Voice from the Community: The Human Impact
The success of the Sarmaan Project is not just in the numbers—it’s in the stories of the families whose children have benefited from this intervention. Hon. Emem Joseph Uwah, a prominent stakeholder from Ikono, lauded the commitment of the project officials, many of whom braved difficult terrains and challenging environments to reach all eligible children.
“They were diligent, passionate, and fearless. Even in riverine and remote areas, they delivered,” Uwah stated emotionally. “The health of our children has improved, and we are thankful to everyone involved — from the WHO to the federal and state governments — for making Ikono the starting point.”
Akwa Ibom’s Health Leadership Commends Federal Choice
Dr. Eno Attah, the Executive Secretary of the Akwa Ibom State Primary Health Care Development Agency, echoed similar sentiments. Represented by Mrs. Margaret Etim, Director of Health Education and Promotion, Dr. Attah acknowledged the vulnerability of children and the importance of targeted interventions.
“Our children are often unable to express how they feel or where they hurt, which makes early intervention crucial,” Etim noted. “This project has shown that with the right tools and methods, we can significantly reduce the risk of death from common infections.”
She called for sustained support and the expansion of the project to other LGAs, highlighting the positive feedback received from health workers and caregivers across the state.
Lessons Learned and the Way Forward
The pilot phase of the Sarmaan Project has yielded critical insights that could influence Nigeria’s future health policies. One of the biggest takeaways is the validation of azithromycin as a viable tool for reducing infant mortality when administered correctly and responsibly.
However, experts caution that the success of this project should not lead to complacency. Antibiotic resistance remains a global threat, and the project’s focus on monitoring resistance trends is a necessary safeguard.
Dr. Wamiyel-Mshella stressed the importance of data-driven expansion. “Before we consider scaling up, we must rigorously analyze the safety and resistance data. If we can demonstrate that the benefits outweigh any potential risks, then we can confidently move forward.”
Call for Policy Action and Public Investment
As the pilot wraps up, stakeholders are urging the Akwa Ibom State Government and the Federal Ministry of Health to adopt the findings and incorporate them into broader child health policies. There’s also a call for increased public investment in similar preventive health measures, especially those targeting infants and young children.
Community leaders, parents, and health professionals in Ikono LGA have all seen firsthand the life-changing impact of the Sarmaan Project. Now, the hope is that this impact will not remain confined to a single LGA but will ripple outwards to touch lives across the entire country.
Conclusion: A Milestone with National Implications
The Sarmaan Project has achieved more than just treating 36,000 children — it has proven that with vision, collaboration, and commitment, innovative public health solutions can thrive even in challenging environments. Its success in Ikono LGA provides a powerful model that can be replicated to improve child survival rates across Nigeria.
As the country continues its fight against child mortality, the story of Sarmaan is a reminder that even the smallest interventions, when backed by science and compassion, can create life-saving ripple effects that last for generations.